MAXIMUS, Inc. (NYSE:MMS) declared a quarterly dividend on Thursday, January 10th, RTT News reports. Investors of record on Friday, February 15th will be given a dividend of 0.25 per share by the health services provider on Thursday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend is Thursday, February 14th.
MAXIMUS has increased its dividend by an average of 28.8% annually over the last three years. MAXIMUS has a payout ratio of 30.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect MAXIMUS to earn $4.05 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 24.7%.
Shares of NYSE MMS opened at $69.89 on Friday. The company has a current ratio of 2.32, a quick ratio of 2.91 and a debt-to-equity ratio of 0.11. MAXIMUS has a one year low of $60.00 and a one year high of $72.45. The firm has a market capitalization of $4.51 billion, a price-to-earnings ratio of 20.56, a PEG ratio of 1.93 and a beta of 1.02.
In other MAXIMUS news, Director Russell A. Beliveau sold 1,000 shares of the company’s stock in a transaction on Wednesday, January 2nd. The stock was sold at an average price of $64.14, for a total value of $64,140.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Vice Chairman Richard A. Montoni sold 30,000 shares of the company’s stock in a transaction on Tuesday, December 4th. The shares were sold at an average price of $72.03, for a total value of $2,160,900.00. Following the completion of the transaction, the insider now directly owns 429,874 shares in the company, valued at $30,963,824.22. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 67,902 shares of company stock worth $4,761,681. Insiders own 2.20% of the company’s stock.
A number of brokerages have commented on MMS. Zacks Investment Research lowered MAXIMUS from a “buy” rating to a “hold” rating in a report on Tuesday, January 29th. ValuEngine raised MAXIMUS from a “hold” rating to a “buy” rating in a report on Friday, November 30th.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Featured Story: Why is the conference call important?
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.